- Home
- LILA vs TVTX Comparison
LILA vs TVTX Comparison
Compare LILA & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILA
- TVTX
- Stock Information
- Founded
- LILA 2017
- TVTX 2008
- Country
- LILA Bermuda
- TVTX United States
- Employees
- LILA N/A
- TVTX N/A
- Industry
- LILA Cable & Other Pay Television Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- LILA Telecommunications
- TVTX Health Care
- Exchange
- LILA Nasdaq
- TVTX Nasdaq
- Market Cap
- LILA 1.3B
- TVTX 1.5B
- IPO Year
- LILA N/A
- TVTX N/A
- Fundamental
- Price
- LILA $8.21
- TVTX $25.60
- Analyst Decision
- LILA Sell
- TVTX Strong Buy
- Analyst Count
- LILA 1
- TVTX 16
- Target Price
- LILA $6.50
- TVTX $35.20
- AVG Volume (30 Days)
- LILA 230.7K
- TVTX 2.7M
- Earning Date
- LILA 11-05-2025
- TVTX 10-30-2025
- Dividend Yield
- LILA N/A
- TVTX N/A
- EPS Growth
- LILA N/A
- TVTX N/A
- EPS
- LILA N/A
- TVTX N/A
- Revenue
- LILA $4,409,700,000.00
- TVTX $333,865,000.00
- Revenue This Year
- LILA $1.37
- TVTX $83.87
- Revenue Next Year
- LILA N/A
- TVTX $40.99
- P/E Ratio
- LILA N/A
- TVTX N/A
- Revenue Growth
- LILA N/A
- TVTX 87.94
- 52 Week Low
- LILA $4.26
- TVTX $12.91
- 52 Week High
- LILA $10.79
- TVTX $28.69
- Technical
- Relative Strength Index (RSI)
- LILA 56.09
- TVTX 67.53
- Support Level
- LILA $8.09
- TVTX $23.22
- Resistance Level
- LILA $8.49
- TVTX $26.53
- Average True Range (ATR)
- LILA 0.22
- TVTX 1.32
- MACD
- LILA -0.01
- TVTX -0.07
- Stochastic Oscillator
- LILA 50.00
- TVTX 80.78
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.